Armata Pharmaceuticals, Inc.
ARMPAs of the close on Sep 25, 2026
Price
$3.74
Market cap
—
The cover-page share count does not match the latest report's share count
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Armata Pharmaceuticals, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 13 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Apr 28, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Armata Pharmaceuticals, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2022-03-31 · Innoviva, Inc.: Larger than 21 of the 23 other insider purchases of Common Stock on file. SEC filing
- 2020-03-27 · Innoviva, Inc.: Larger than 22 of the 23 other insider purchases of Common Stock on file. SEC filing
- 2015-03-16 · KIRK RANDAL J: Larger than all 23 other insider purchases of Common Stock on file. SEC filing
- 2009-10-12 · MARXE AUSTIN W & GREENHOUSE DAVID M: Larger than 20 of the 21 other insider sales of Common Stock on file. SEC filing
- 2009-10-08 · MARXE AUSTIN W & GREENHOUSE DAVID M: Larger than all 21 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2018-03-22–2018-03-22: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2017-09-19–2017-09-19: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2017-06-29–2017-06-29: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2015-10-05–2015-10-06: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2015-03-16–2015-03-16: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2015-03-16–2015-03-16: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2023-01-10 | Innoviva, Inc. · Director, 10% owner | Convertible Debt convertible into Common Stock | P — Open market or private purchase | +unknown | 30,000,000.00 | SEC filing |
| 2022-03-31 | Innoviva, Inc. · Director, 10% owner | Common Stock | P — Open market or private purchase | +5,385,208 | 5.00 | SEC filing |
| 2022-03-31 | Innoviva, Inc. · Director, 10% owner | Warrants to Purchase Common Stock | P — Open market or private purchase | +0 | 5.00 | SEC filing |
| 2022-02-09 | Innoviva, Inc. · Director, 10% owner | Warrants to Purchase Common Stock | P — Open market or private purchase | +1,807,396 | 5.00 | SEC filing |
| 2022-02-09 | Innoviva, Inc. · Director, 10% owner | Common Stock | P — Open market or private purchase | +3,614,792 | 5.00 | SEC filing |
| 2021-10-29 | Innoviva, Inc. · Director, 10% owner | Common Stock | P — Open market or private purchase | +1,212,122 | 3.30 | SEC filing |
| 2021-03-17 | Innoviva, Inc. · Director, 10% owner | Warrants to Purchase Common Stock | P — Open market or private purchase | +4,285,935 | 3.25 | SEC filing |
| 2021-03-17 | Innoviva, Inc. · Director, 10% owner | Common Stock | P — Open market or private purchase | +4,285,935 | 3.25 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-04-24 | Gilmer Daniel B. · Director | Stock Options (Right to Buy) | A — Grant, award, or other acquisition | +51,280 | SEC filing |
| 2026-03-14 | Kyme Pierre · Chief Business Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −1,030 | SEC filing |
| 2026-03-14 | Birx Deborah · Chief Executive Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −4,919 | SEC filing |
| 2026-03-09 | PATTI JOSEPH M · Director | Stock Options (Right to Buy) | A — Grant, award, or other acquisition | +25,640 | SEC filing |
| 2026-03-09 | Odysseas Kostas D · Director | Stock Options (Right to Buy) | A — Grant, award, or other acquisition | +25,640 | SEC filing |
| 2026-03-09 | Kramer Robin · Director | Stock Options (Right to Buy) | A — Grant, award, or other acquisition | +25,640 | SEC filing |
| 2026-03-09 | Kyme Pierre · Chief Business Officer | Stock Options (Right to Buy) | A — Grant, award, or other acquisition | +183,142 | SEC filing |
| 2026-03-09 | House David Duane · SVP, Finance, and PFO | Stock Options (Right to Buy) | A — Grant, award, or other acquisition | +109,885 | SEC filing |
Showing 8 of 24 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2019-05-09 | COOK JEREMY CURNOCK · Director | Warrant to Purchase Common Stock | J — Other acquisition or disposition | −46,666 | SEC filing |
| 2019-05-09 | PERRY MICHAEL S · Director | Warrant to Purchase Common Stock | J — Other acquisition or disposition | −46,666 | SEC filing |
| 2016-04-08 | COOK JEREMY CURNOCK · Director | Warrant to Purchase Common Stock | D — Disposition to the issuer | −35,714 | SEC filing |
Showing 3 of 3 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.